Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry

被引:19
作者
Pocock, Stuart J. [1 ]
Brieger, David [2 ,3 ]
Gregson, John [1 ]
Chen, Ji Y. [4 ]
Cohen, Mauricio G. [5 ]
Goodman, Shaun G. [6 ]
Granger, Christopher B. [7 ]
Grieve, Richard [1 ]
Nicolau, Jose C. [8 ]
Simon, Tabassome [9 ,10 ,11 ]
Westermann, Dirk [12 ,13 ]
Yasuda, Satoshi [14 ]
Hedman, Katarina [15 ]
Rennie, Kirsten L. [1 ,16 ]
Sundell, Karolina Andersson [15 ]
机构
[1] London Sch Hyg & Trop Med, Dept Med Stat, London, England
[2] Concord Hosp, Div Cardiol, Sydney, NSW, Australia
[3] Univ Sydney, Sydney, NSW, Australia
[4] Guangdong Gen Hosp, Dept Cardiol, Prov Key Lab Coronary Dis, Guangzhou, Guangdong, Peoples R China
[5] Univ Miami, Miller Sch Med, Cardiovasc Div, Miami, FL 33136 USA
[6] Univ Toronto, St Michaels Hosp, Terrence Donnelly Heart Ctr, Toronto, ON, Canada
[7] Duke Univ, Med Ctr, Duke Clin Res Inst, Cardiac Intens Care Unit, Durham, NC USA
[8] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Coraca InCor, Sao Paulo, SP, Brazil
[9] AP HP, Dept Clin Pharmacol, Paris, France
[10] AP HP, Clin Res Platform East Paris, Paris, France
[11] Sorbonne Univ, UPMC Paris 06, Dept Pharmacol, Paris, France
[12] Univ Heart Ctr Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany
[13] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Lubeck Kiel, Hamburg, Germany
[14] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan
[15] AstraZeneca, Global Med Affairs Cardiovasc Renal & Metab, Gothenburg, Sweden
[16] Oxon Epidemiol UK, London, England
关键词
cardiac risk factors and prevention; coronary artery disease; myocardial infarction; CORONARY-ARTERY-DISEASE; CARE RESOURCE UTILIZATION; LONG-TERM RISK; MYOCARDIAL-INFARCTION; CLINICAL MANAGEMENT; PROGNOSTIC MODELS; HEART-DISEASE; OUTCOMES; PREVENTION; VORAPAXAR;
D O I
10.1002/clc.23283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Risk prediction tools are lacking for patients with stable disease some years after myocardial infarction (MI). Hypothesis A practical long-term cardiovascular risk index can be developed. Methods The long-Term rIsk, Clinical manaGement and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients prospective global registry enrolled patients 1 to 3 years post-MI (369 centers; 25 countries), all with >= 1 risk factor (age >= 65 years, diabetes mellitus requiring medication, second prior MI, multivessel coronary artery disease, or chronic non-end-stage kidney disease [CKD]). Self-reported health was assessed with EuroQoL-5 dimensions. Multivariable Poisson regression models were used to determine key predictors of the primary composite outcome (MI, unstable angina with urgent revascularization [UA], stroke, or all-cause death) over 2 years. Results The primary outcome occurred in 621 (6.9%) of 9027 eligible patients: death 295 (3.3%), MI 195 (2.2%), UA 103 (1.1%), and stroke 58 (0.6%). All events accrued linearly. In a multivariable model, 11 significant predictors of primary outcome (age >= 65 years, diabetes, second prior MI, CKD, history of major bleed, peripheral arterial disease, heart failure, cardiovascular hospitalization (prior 6 months), medical management (index MI), on diuretic, and poor self-reported health) were identified and combined into a user-friendly risk index. Compared with lowest-risk patients, those in the top 16% had a rate ratio of 6.9 for the primary composite, and 18.7 for all-cause death (overall c-statistic; 0.686, and 0.768, respectively). External validation was performed using the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events registry (c-statistic; 0.748, and 0.849, respectively). Conclusions In patients >1-year post-MI, recurrent cardiovascular events and deaths accrue linearly. A simple risk index can stratify patients, potentially helping to guide management.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 30 条
[1]   The Design and Rationale of the Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE) [J].
Aliprandi-Costa, B. ;
Ranasinghe, I. ;
Turnbull, F. ;
Brown, A. ;
Kritharides, L. ;
Patel, A. ;
Chew, D. ;
Walters, D. ;
Rankin, J. ;
Iltong, M. ;
Meredith, I. ;
Cass, A. ;
Brieger, D. .
HEART LUNG AND CIRCULATION, 2013, 22 (07) :533-541
[2]   Development and Validation of a Cardiovascular Risk Assessment Model in Patients With Established Coronary Artery Disease [J].
Battes, Linda ;
Barendse, Rogier ;
Steyerberg, Ewout W. ;
Simoons, Maarten L. ;
Deckers, Jaap W. ;
Nieboer, Daan ;
Bertrand, Michel ;
Ferrari, Roberto ;
Remme, Willem J. ;
Fox, Kim ;
Takkenberg, Johanna J. M. ;
Boersma, Eric ;
Kardys, Isabella .
AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (01) :27-33
[3]   International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis [J].
Bhatt, DL ;
Steg, PG ;
Ohman, EM ;
Hirsch, AT ;
Ikeda, Y ;
Mas, JL ;
Goto, S ;
Liau, CS ;
Richard, AJ ;
Röther, J ;
Wilson, PWF ;
Andersen-Dalheim, H ;
Anderson, P ;
Anell, B ;
Arber, S ;
Armstrong, K ;
Arnot, D ;
Baldam, A ;
Barratt, I ;
Barresi, S ;
Beder, J ;
Benson, M ;
Bergman, F ;
Best, J ;
Bhasim, R ;
Bovell, G ;
Bowman, N ;
Brkic, M ;
Bromberger, D ;
Brown, D ;
Brown, J ;
Brownstein, M ;
Bruce, A ;
Buonopane, J ;
Burns, S ;
Butler, A ;
Byrne, D ;
Carson, J ;
Cassimatis, P ;
Chaffey, G ;
Chambers, D ;
Chan, WJ ;
Chan, B ;
Cheatham, J ;
Chen, R ;
Cheong, B ;
Cheung, C ;
Chin, J ;
Chiu, A ;
Choo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (02) :180-189
[4]   Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction [J].
Bohula, Erin A. ;
Bonaca, Marc P. ;
Braunwald, Eugene ;
Aylward, Philip E. ;
Corbalan, Ramon ;
De Ferrari, Gaetano M. ;
He, Ping ;
Lewis, Basil S. ;
Merlini, Piera A. ;
Murphy, Sabina A. ;
Sabatine, Marc S. ;
Scirica, Benjamin M. ;
Morrow, David A. .
CIRCULATION, 2016, 134 (04) :304-+
[5]   Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction [J].
Bonaca, Marc P. ;
Bhatt, Deepak L. ;
Cohen, Marc ;
Steg, Philippe Gabriel ;
Storey, Robert F. ;
Jensen, Eva C. ;
Magnani, Giulia ;
Bansilal, Sameer ;
Fish, M. Polly ;
Im, Kyungah ;
Bengtsson, Olof ;
Ophuis, Ton Oude ;
Budaj, Andrzej ;
Theroux, Pierre ;
Ruda, Mikhail ;
Hamm, Christian ;
Goto, Shinya ;
Spinar, Jindrich ;
Nicolau, Jose Carlos ;
Kiss, Robert G. ;
Murphy, Sabina A. ;
Wiviott, Stephen D. ;
Held, Peter ;
Braunwald, Eugene ;
Sabatine, Marc S. ;
Morin, Suzanne ;
Dantzer, Emily ;
Acquilano, Dayle ;
McGuire, Rachael L. ;
Gannon, Joseph B. ;
Gershman, Elaine ;
Ahlbom, Ann Maxe ;
Boberg, Barbro ;
Abola, Maria Teresa ;
Ardissino, Diego ;
Aylward, Philip ;
Corbalan, Ramon ;
Dalby, Anthony ;
Diaz, Rafael ;
Hu, Dayi ;
Isaza, Daniel ;
Kamensky, Gabriel ;
Kiss, Robert ;
Kontny, Frederic ;
Lopez-Sendon, Jose ;
Medina, Felix ;
Montalescot, Gilles ;
Nicolau, Jose ;
Paolasso, Ernesto ;
Parkhomenko, Alexander .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (19) :1791-1800
[6]  
Brieger D, 2018, EUR HEART J, V39, P1083
[7]   EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[8]   Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients [J].
Clayton, TC ;
Lubsen, J ;
Pocock, SJ ;
Vokó, Z ;
Kirwan, BA ;
Fox, KAA ;
Poole-Wilson, PA .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7521) :869-872B
[9]  
Craig Benjamin M, 2009, Med Care, V47, P634, DOI 10.1097/MLR.0b013e31819432ba
[10]  
Dixon Simon R, 2005, J Interv Cardiol, V18, P233, DOI 10.1111/j.1540-8183.2005.00039.x